ALYSSA YOUNG: Open Payments
NPI 1811641459 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 13 payments from 8 companies in 2025. Trend: 2023 $494 · 2024 $201 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $189 |
| ABBVIE INC. | 4 | $72 |
| GENZYME CORPORATION | 1 | $62 |
| Lilly USA, LLC | 1 | $29 |
| QOL Medical, LLC | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $16 |
Products named: VOQUEZNA, DUPIXENT, CREON, OMVOH, Sucraid, XIFAXAN, RINVOQ, LINZESS.
Industry payments across NH — which companies pay providers there.
